These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 30226946

  • 1. Sensitivity surveillance of Pseudomonas aeruginosa isolates for several antibacterial agents in Chubu area (2013-2014).
    Kakumoto A, Okade H, Misuyama J, Yamaoka K, Asano Y, Matsukawa Y, Suematsu H, Sawamura H, Matsubara S, Shibata N, Watanabe K, Yamamoto Y, Iwasaki H, Yamagishi Y, Mikamo H, Chubu Anti-biogram Study Group.
    Jpn J Antibiot; 2016 Oct; 69(5):327-341. PubMed ID: 30226946
    [Abstract] [Full Text] [Related]

  • 2. [Sensitivity surveillance of Pseudomonas aeruginosa isolates for several antibacterial agents in Gifu and Aichi prefecture (2008)].
    Fujiwara M, Mizunaga S, Nomura N, Mitsuyama J, Hashido H, Yamaoka K, Matsukawa Y, Asano Y, Matsubara S, Sawamura H, Miyabe T, Suematsu H, Mikamo H, Teraji M, Watanabe K, Research Laboratories, Toyama Chemical Co Ltd, Working Group of Tokai Anti-biogram Study Group.
    Jpn J Antibiot; 2012 Feb; 65(1):15-26. PubMed ID: 22808691
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents.
    Fujimura T, Anan N, Sugimori G, Watanabe T, Jinushi Y, Yoshida I, Yamano Y.
    Int J Antimicrob Agents; 2009 Dec; 34(6):523-8. PubMed ID: 19748767
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    Watanabe Y, Fujiue Y, Yano S, Shimizu S, Muroki K, Doi M, Kuwabara M.
    Jpn J Antibiot; 2006 Apr; 59(2):65-71. PubMed ID: 16805317
    [Abstract] [Full Text] [Related]

  • 8. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Apr; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of sodium mercaptoacetic acid on different antimicrobial disks in the sodium mercaptoacetic acid double disk synergy test for detection of IMP-1 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Japan.
    Sakanashi D, Miyazaki N, Kawamoto Y, Ohno T, Yamada A, Koita I, Miyajima S, Suematsu H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2019 Jan; 25(1):75-77. PubMed ID: 30100401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan.
    Takesue Y, Watanabe A, Hanaki H, Kusachi S, Matsumoto T, Iwamoto A, Totsuka K, Sunakawa K, Yagisawa M, Sato J, Oguri T, Nakanishi K, Sumiyama Y, Kitagawa Y, Wakabayashi G, Koyama I, Yanaga K, Konishi T, Fukushima R, Seki S, Imai S, Shintani T, Tsukada H, Tsukada K, Omura K, Mikamo H, Takeyama H, Kusunoki M, Kubo S, Shimizu J, Hirai T, Ohge H, Kadowaki A, Okamoto K, Yanagihara K.
    J Infect Chemother; 2012 Dec; 18(6):816-26. PubMed ID: 23143280
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y, Abe M, Ono N, Araki M, Horimi T, Takahashi I.
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA, Shortridge D, Sader HS, Castanheira M, Flamm RK.
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.